BCL2A1 and cancer: Analysis of the potential correlation between the expression of 5 core protein coding genes and drug sensitivity in different human cancer cell lines from CellMiner database, which showed that the expression of BCL2A1 was positively correlated with the drug sensitivity of Vemurafenib (Figure 7A).